These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6511725)

  • 41. Significance of the quantitative determination of "fibrin degradation products" in renal diseases.
    Chin Med J (Engl); 1980 Jul; 93(7):483-6. PubMed ID: 6772396
    [No Abstract]   [Full Text] [Related]  

  • 42. [The diagnostic usefulness of cholinesterase in pleural exudates].
    García Pachón E; Padilla Navas I
    Rev Clin Esp; 1997 Jun; 197(6):402-5. PubMed ID: 9304130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic approach to pleural effusion in adults.
    Porcel JM; Light RW
    Am Fam Physician; 2006 Apr; 73(7):1211-20. PubMed ID: 16623208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diagnostic importance of fibrinogen degradation products in viral hepatitis].
    Zhitar VD
    Klin Med (Mosk); 1978 Aug; 56(8):95-9. PubMed ID: 703222
    [No Abstract]   [Full Text] [Related]  

  • 45. [Diagnostic significance of assaying glycoproteins, immunoglobulins, complement fractions and carcinoembryonic antigen in pleural and peritoneal exudates and transudates].
    Berti P; Sgherri L; Bartoli P; Cioni R; Ceccotti MG; Nozzoli F
    Quad Sclavo Diagn; 1981 Dec; 17(4):483-94. PubMed ID: 7347828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diagnostic value of carcinoembryonic antigen (CEA) concentration in malignant pleural and ascitic fluids - in comparison with cytodiagnosis (author's transl)].
    Makino M; Matsui H; Kato S; Koshimizu M; Kimura M
    Rinsho Byori; 1981; 29(7):736-40. PubMed ID: 7328807
    [No Abstract]   [Full Text] [Related]  

  • 47. [Deviations in glycoprotein contents in malignant ascitic fluid and pleural effusions].
    Ohtani H
    Rinsho Byori; 1983 Sep; 31(9):940-4. PubMed ID: 6663770
    [No Abstract]   [Full Text] [Related]  

  • 48. Fibrinogen degradation products (F.D.P.) in ascitic fluid of patients affected by ovarian cancer.
    Paternoster D; Maggino T; Valente S; Pengo V; Marchesoni D
    Eur J Gynaecol Oncol; 1981; 2(3):127-8. PubMed ID: 7347682
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cytomorphological and cytochemical studies of pleural and peritoneal cavity effusions].
    Bauer Z; Crepinko I; Jakasa V
    Acta Med Iugosl; 1973; 27(3):249-60. PubMed ID: 4721109
    [No Abstract]   [Full Text] [Related]  

  • 50. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
    Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M
    J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Procoagulant activity in children with community acquired pneumonia, pleural effusion and empyema.
    Michelin E; Snijders D; Conte S; Dalla Via P; Tagliaferro T; Da Dalt L; Monciotti CM; Simioni P; Stefanutti G; Ghirardo V; Gamba P; Barbato A
    Pediatr Pulmonol; 2008 May; 43(5):472-5. PubMed ID: 18383331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Determination of carcinoembryonic antigen (CEA) in the pleural and peritoneal fluid. Diagnostic value?].
    Lepilliez A; Martin F; Delavenne J
    Nouv Presse Med; 1981 Jan; 10(2):105-6. PubMed ID: 7465350
    [No Abstract]   [Full Text] [Related]  

  • 53. The preoperative diagnosis of malignancy of ovarian cysts.
    Tropé C
    Neoplasma; 1981; 28(1):117-21. PubMed ID: 7279055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Coagulation and fibrinolysis parameters in neoplastic pleural exudates].
    Tałałaj J
    Pneumonol Alergol Pol; 1995; 63(5-6):339-43. PubMed ID: 7581071
    [No Abstract]   [Full Text] [Related]  

  • 55. [Fibrin(ogen degradation product concentration (SFP) as a diagnostic parameter for the differentiation of artifical and essential blood in cerebrospinal fluid].
    Hindersin P; Heidrich R
    Psychiatr Neurol Med Psychol (Leipz); 1978 Jan; 30(1):36-9. PubMed ID: 643973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytology of fluids from pleural, peritoneal and pericardial cavities in children. A comprehensive survey.
    Hallman JR; Geisinger KR
    Acta Cytol; 1994; 38(2):209-17. PubMed ID: 8147212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibrinogen-fibrin degradation products.
    Kwaan HC
    Ann Clin Lab Sci; 1980; 10(3):234-7. PubMed ID: 7396389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Practical management of pleural effusion].
    Porcel-Pérez JM
    An Med Interna; 2002 Apr; 19(4):202-8. PubMed ID: 12090064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Usefulness and limitations of the differential cell count in the diagnosis of tuberculous pleural effusions].
    Coca A; Font J; Faus R; Torres A; Font P; Ingelmo M; Balcells A
    Med Clin (Barc); 1982 Nov 1-15; 79(8):360-4. PubMed ID: 7176749
    [No Abstract]   [Full Text] [Related]  

  • 60. The significance of cytological examination of the pleural fluid in the diagnosis of pleural effusion in Nigerians.
    Onadeko BO; Junaid TA; Odor EI
    Ir J Med Sci; 1978 Nov; 147(11):383-8. PubMed ID: 721396
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.